CN101412699A - Preparation of 2-(3-carboxaldehyde-4-hydroxy phenyl)-4-methyl-5-thiazole ethyl formate - Google Patents
Preparation of 2-(3-carboxaldehyde-4-hydroxy phenyl)-4-methyl-5-thiazole ethyl formate Download PDFInfo
- Publication number
- CN101412699A CN101412699A CN 200710047267 CN200710047267A CN101412699A CN 101412699 A CN101412699 A CN 101412699A CN 200710047267 CN200710047267 CN 200710047267 CN 200710047267 A CN200710047267 A CN 200710047267A CN 101412699 A CN101412699 A CN 101412699A
- Authority
- CN
- China
- Prior art keywords
- preparation
- methyl
- ethyl
- reaction
- hydroxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 title claims abstract 10
- 238000002360 preparation method Methods 0.000 title claims description 34
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 47
- LOCYSKNNFCGDTR-UHFFFAOYSA-N ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate Chemical compound CC1=C(C(=O)OCC)SC(C=2C=CC(O)=CC=2)=N1 LOCYSKNNFCGDTR-UHFFFAOYSA-N 0.000 claims abstract description 21
- VDTNKXSVUGXUOJ-UHFFFAOYSA-N chembl2441358 Chemical compound NC(=S)C1=CC=C(O)C=C1 VDTNKXSVUGXUOJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- CVNOWLNNPYYEOH-UHFFFAOYSA-N 4-cyanophenol Chemical compound OC1=CC=C(C#N)C=C1 CVNOWLNNPYYEOH-UHFFFAOYSA-N 0.000 claims abstract description 15
- RDULEYWUGKOCMR-UHFFFAOYSA-N ethyl 2-chloro-3-oxobutanoate Chemical compound CCOC(=O)C(Cl)C(C)=O RDULEYWUGKOCMR-UHFFFAOYSA-N 0.000 claims abstract description 15
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical group OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- 239000003960 organic solvent Substances 0.000 claims description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 10
- 230000002378 acidificating effect Effects 0.000 claims description 10
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- 238000000354 decomposition reaction Methods 0.000 claims description 3
- -1 2-(4-hydroxyl phenyl)- Ethyl 4-methyl-5-thiazolecarboxylate Chemical compound 0.000 claims description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 1
- 150000003936 benzamides Chemical class 0.000 claims 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract description 9
- 239000007787 solid Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 9
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 7
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 229920000137 polyphosphoric acid Polymers 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000003445 Hantzsch reaction Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 150000003556 thioamides Chemical class 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- BQSJTQLCZDPROO-UHFFFAOYSA-N febuxostat Chemical compound C1=C(C#N)C(OCC(C)C)=CC=C1C1=NC(C)=C(C(O)=O)S1 BQSJTQLCZDPROO-UHFFFAOYSA-N 0.000 description 1
- 229960005101 febuxostat Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
Abstract
本发明提供一种2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯的制备方法,该方法以对氰基苯酚和硫代乙酰胺为原料,反应得到4-羟基硫代苯甲酰胺,所得产物和2-氯乙酰乙酸乙酯反应得到2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯,再与乌洛托品反应得到2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯。The invention provides a method for preparing 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazole ethyl formate. The method uses p-cyanophenol and thioacetamide as raw materials, The reaction gives 4-hydroxythiobenzamide, and the resulting product reacts with ethyl 2-chloroacetoacetate to obtain ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate, which is then reacted with uroto Product reaction to obtain ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate.
Description
技术领域 technical field
本发明涉及药物化学领域,具体涉及一种2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯的制备方法。The invention relates to the field of medicinal chemistry, in particular to a preparation method of ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate.
背景技术 Background technique
2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯是抗高尿酸血症药物非布司他(Febuxostat)合成过程中的重要中间体,其结构如下式(1)所示。Ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate is an important intermediate in the synthesis of the antihyperuricemia drug Febuxostat. Its structure It is shown in the following formula (1).
JP1045733和JP11060552报道了式I化合物的合成方法,以对氰基苯酚和硫代乙酰胺为原料,在多聚磷酸中与2-氯乙酰乙酸乙酯进行Hantzch反应得到2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯,反应在85℃,如下式II所示。然后式II化合物与乌洛托品在多聚磷酸中于80℃进行Duff-Bills反应,经处理后得到式I化合物。JP1045733 and JP11060552 report the synthetic method of formula I compound, take p-cyanophenol and thioacetamide as raw material, carry out Hantzch reaction with ethyl 2-chloroacetoacetate in polyphosphoric acid to obtain 2-(4-hydroxyphenyl )-4-methyl-5-thiazolecarboxylic acid ethyl ester, reacted at 85°C, as shown in the following formula II. Then the compound of formula II and hexatropine are subjected to Duff-Bills reaction in polyphosphoric acid at 80° C. to obtain the compound of formula I after treatment.
该合成路线所提供的制备方法中,式II化合物的收率较低,仅为46%,由式II化合物制备式I化合物的收率为70%,这无疑使制备成本增加;并且在制备式I化合物的两步反应中均使用了多聚磷酸,在后处理中会产生大量的三废物质。In the preparation method provided by this synthetic route, the yield of the compound of formula II is low, only 46%, and the yield of the compound of formula I prepared by the compound of formula II is 70%, which undoubtedly increases the cost of preparation; and in the preparation of formula II All used polyphosphoric acid in the two-step reaction of I compound, can produce a large amount of three waste substances in aftertreatment.
文献The chemistry of Hereocyclic compounds:Thiazole and itsderivative,1979,34(1):165记载了以硫代酰胺类化合物合成噻唑环类衍生物的制备工艺,其中提及,采用乙醇、1,4-二氧六环作为溶剂,五硫化二磷催化时可以得到与式II类似的噻唑环类衍生物,收率最高可达85%。The literature The chemistry of Hereocyclic compounds: Thiazole and its derivative, 1979, 34 (1): 165 records the preparation process for the synthesis of thiazole ring derivatives with thioamide compounds, which mentions that ethanol, 1,4-diox When the hexacyclic ring is used as a solvent and phosphorus pentasulfide is catalyzed, thiazole ring derivatives similar to formula II can be obtained, and the yield can reach up to 85%.
此外,根据对上述文献的总结,可以得知Hantzsch反应的机理如下:In addition, according to the summary of the above literature, it can be known that the mechanism of the Hantzsch reaction is as follows:
另外,所述Duff-Bills反应是酚类化合物在邻位或者间位上引入醛基一种方法。在文献JP1045733中用PPA作为溶剂,收率尚可(70%),但是后处理烦琐,三废物质产生量大,而且PPA流动性差,大批量生产比较困难。In addition, the Duff-Bills reaction is a method for phenolic compounds to introduce aldehyde groups at the ortho or meta positions. In the document JP1045733, PPA is used as a solvent, and the yield is acceptable (70%), but the aftertreatment is cumbersome, the three wastes are produced in a large amount, and PPA has poor fluidity, making mass production more difficult.
相关文献Tetrehedron 1968,24:5001和J.Org.Chem,1972,37(24):3972报道Duff-Bills多用醋酸、硼酸/甘油、三氟乙酸作为反应溶剂,其中以醋酸、硼酸/甘油作为溶剂的收率通常为50%左右,三氟乙酸作溶剂时收率较高(95%),但主要为酚羟基对位的产物。Related literature Tetrehedron 1968, 24:5001 and J.Org.Chem, 1972,37 (24): 3972 report that Duff-Bills uses acetic acid, boric acid/glycerin, trifluoroacetic acid as reaction solvent more, wherein with acetic acid, boric acid/glycerin as solvent The yield is usually about 50%, and the yield is higher (95%) when trifluoroacetic acid is used as a solvent, but it is mainly the product of the para-position of the phenolic hydroxyl group.
Duff-Bills的反应机理如下:The reaction mechanism of Duff-Bills is as follows:
发明内容: Invention content:
本发明的目的在于提供一种2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯的合成方法。The object of the present invention is to provide a kind of synthetic method of ethyl 2-(3-formaldehyde-4-hydroxyl phenyl)-4-methyl-5-thiazolecarboxylate.
在对比文献JP1045733所示的制备方法中,硫代乙酰胺与对氰基苯酚反应生成式III所示的4-羟基-硫代苯甲酰胺,其再与2-氯乙酰乙酸乙酯进行环合得到噻唑环。In the preparation method shown in comparative document JP1045733, thioacetamide reacts with p-cyanophenol to generate 4-hydroxyl-thiobenzamide shown in formula III, which is then cyclized with ethyl 2-chloroacetoacetate The thiazole ring is obtained.
合成噻唑环的关键在于硫代酰胺在反应过程中的稳定性,硫代酰胺通常在酸性条件下不稳定。基于理论研究和实际分析结果,发明人认为文献JP1045733所示Hantzsch反应收率低的主要原因是使用了PPA这种酸性溶剂,造成了式III所示4-羟基-硫代苯甲酰胺分解,从而导致收率降低。The key to the synthesis of thiazole rings lies in the stability of thioamides during the reaction, which are usually unstable under acidic conditions. Based on theoretical research and actual analysis results, the inventor believes that the main reason for the low yield of Hantzsch reaction shown in document JP1045733 is to use the acidic solvent of PPA, which causes the decomposition of 4-hydroxy-thiobenzamide shown in formula III, thereby lead to a decrease in yield.
在文献JP1045733和JP11060552所描述的制备工艺中,对氰基苯酚与硫代乙酰胺在酸性溶剂PPA反应得到4-羟基硫代苯甲酰胺后,不经分离直接加入2-氯乙酰乙酸乙酯继续反应,最终得到2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯,收率仅为46%。虽然对氰基苯酚与硫代乙酰胺是在酸性溶剂PPA中生成4-羟基硫代苯甲酰胺,但是该反应在温和条件即可完成,例如,其在40℃左右的温度下。而后续的用4-羟基硫代苯甲酰胺与2-氯乙酰乙酸乙酯反应得到2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯的过程需要更高的反应温度,例如70℃。在温度升高时,上述的产物4-羟基硫代苯甲酰胺在酸性环境中将变得不稳定,其容易分解。这有可能是收率较低的原因。In the preparation process described in documents JP1045733 and JP11060552, after p-cyanophenol and thioacetamide react in acidic solvent PPA to obtain 4-hydroxythiobenzamide, ethyl 2-chloroacetoacetate is directly added without separation to continue After the reaction, ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate was finally obtained, and the yield was only 46%. Although p-cyanophenol and thioacetamide generate 4-hydroxythiobenzamide in the acidic solvent PPA, the reaction can be completed under mild conditions, for example, at a temperature of about 40°C. However, the subsequent reaction of 4-hydroxythiobenzamide with ethyl 2-chloroacetoacetate to obtain ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate requires a higher reaction rate. temperature, for example 70°C. As the temperature rises, the above-mentioned product 4-hydroxythiobenzamide becomes unstable in an acidic environment, and it decomposes easily. This may be the reason for the lower yield.
鉴于此,本发明主要采用下面两种措施对所述Hantzsch反应加以改进:In view of this, the present invention mainly adopts following two kinds of measures to improve described Hantzsch reaction:
分两步进行反应:即首先单独地用硫代乙酰胺与对氰基苯酚反应得到式III所示的4-羟基-硫代苯甲酰胺;然后再用式III化合物与2-氯乙酰乙酸乙酯在非酸性环境中,例如乙醇或1,4-二氧六环中环合得到式II所示的2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯。这样可以避免式III化合物在反应过程中的自身分解,增加式II化合物的收率,同时由于不再使用多聚磷酸,还减少了三废物质的排放。Reaction is carried out in two steps: that is, at first react separately with thioacetamide and p-cyanophenol to obtain 4-hydroxyl-thiobenzamide shown in formula III; then use formula III compound and ethyl 2-chloroacetoacetate The ester is cyclized in a non-acidic environment such as ethanol or 1,4-dioxane to obtain ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate represented by formula II. In this way, the self-decomposition of the compound of formula III in the reaction process can be avoided, the yield of the compound of formula II can be increased, and at the same time, since polyphosphoric acid is no longer used, the discharge of three wastes is also reduced.
此外,关于背景技术中所述的Duff-Bills反应,在结合理论分析以及实际研究结果后,发明人认为,醋酸、硼酸体系收率较低的原因可能是其酸性不够强,采用三氟乙酸后,收率可大幅提高,虽然其对位选择性较强,但是本发明涉及的合成路线所采用原料2-(4-羟基苯基)-4-甲基-5噻唑甲酸乙酯对位存在噻唑环取代基,所以可以预计唯一的得到邻位取代醛基化合物。In addition, regarding the Duff-Bills reaction described in the background technology, after combining theoretical analysis and actual research results, the inventor believes that the reason for the low yield of acetic acid and boric acid system may be that the acidity is not strong enough. After using trifluoroacetic acid , the yield can be greatly improved, although its para-position selectivity is stronger, but the raw material 2-(4-hydroxyphenyl)-4-methyl-5thiazole ethyl ester used in the synthetic route involved in the present invention has thiazole ring substituents, so can be expected to uniquely give ortho-substituted aldehyde compounds.
具体地,本发明提供的合成方法为,以对氰基苯酚和硫代乙酰胺为原料反应得到式III化合物,所得产物不经纯化直接和2-氯乙酰乙酸乙酯反应得到式II化合物,然后再与乌洛托品在三氟乙酸中反应得到式I化合物。Specifically, the synthesis method provided by the present invention is to use p-cyanophenol and thioacetamide as raw materials to react to obtain the compound of formula III, and the obtained product is directly reacted with ethyl 2-chloroacetoacetate to obtain the compound of formula II without purification, and then Then react with urotropine in trifluoroacetic acid to obtain the compound of formula I.
在得到式III化合物的过程中,对氰基苯酚与硫代乙酰胺在通有盐酸气的有机溶剂中反应,所述有机溶剂包括一种或多种下列溶剂:DMF、乙醇、甲醇等。由于在DMF中所得产物收率最高,溶剂也可回收,所以优选使用DMF作为反应溶剂。反应温度为20~80℃,反应时间为24~48小时。In the process of obtaining the compound of formula III, p-cyanophenol is reacted with thioacetamide in an organic solvent passing through hydrochloric acid gas, and the organic solvent includes one or more of the following solvents: DMF, ethanol, methanol and the like. Since the yield of the product obtained in DMF is the highest and the solvent can also be recovered, it is preferred to use DMF as the reaction solvent. The reaction temperature is 20-80° C., and the reaction time is 24-48 hours.
在得到式II化合物的过程中,其特征是式III化合物与2-氯乙酰乙酸乙酯在有机溶剂中反应,有机溶剂包括一种或多种下列溶剂:乙醇、甲醇、乙酸乙酯、二氧六环,由于乙醇作溶剂收率高,有利于降低生产成本,所以优选乙醇,反应温度为60~80℃。In the process of obtaining the compound of formula II, it is characterized in that the compound of formula III reacts with ethyl 2-chloroacetoacetate in an organic solvent, and the organic solvent includes one or more of the following solvents: ethanol, methanol, ethyl acetate, dioxygen Hexacyclic, because ethanol as a solvent has a high yield and is beneficial to reduce production costs, so ethanol is preferred, and the reaction temperature is 60-80°C.
在得到式I化合物的过程中,其特征是式II化合物与乌洛托品在三氟乙酸中反应。反应温度为80~120℃,由于在100℃时反应比较完全,而且没有杂质产生,所以优选100℃,反应时间为12~24小时。In the process of obtaining the compound of formula I, it is characterized in that the compound of formula II reacts with urotropine in trifluoroacetic acid. The reaction temperature is 80-120°C. Since the reaction is relatively complete at 100°C and no impurities are produced, 100°C is preferred, and the reaction time is 12-24 hours.
本发明经过对工艺的改进具有以下优势:1.收率大幅提高,将制备式I所示化合物的收率由78%提高至97%左右,将制备式II所示化合物的收率由46%提高至70%左右。2.避免了使用多聚磷酸作为反应溶剂,减少了三废的排放。3.反应所用的DMF、三氟乙酸可以回收套用,降低了生产成本。The present invention has the following advantages through the improvement of the process: 1. The yield is greatly improved, the yield of the compound shown in the preparation formula I is increased from 78% to about 97%, and the yield of the compound shown in the preparation formula II is increased from 46% increased to around 70%. 2. Avoiding the use of polyphosphoric acid as a reaction solvent, reducing the discharge of three wastes. 3. The DMF and trifluoroacetic acid used in the reaction can be recycled and reused, which reduces the production cost.
具体实施方式 Detailed ways
下面结合实施例对本发明作进一步阐述,但这些实施例不对本发明构成任何限制。The present invention will be further described below in conjunction with examples, but these examples do not constitute any limitation to the present invention.
下列实施例中,为方便起见,统一用(1)表示2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯,(2)表示2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯,(3)表示4-羟基硫代苯甲酰胺。In the following examples, for convenience, (1) is used to represent ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate, and (2) represents 2-(4 -Hydroxyphenyl)-4-methyl-5-thiazolecarboxylic acid ethyl ester, (3) represents 4-hydroxythiobenzamide.
实施例1:4-羟基硫代苯甲酰胺(3)的制备Embodiment 1: the preparation of 4-hydroxyl thiobenzamide (3)
在5L反应瓶中,将对氰基苯酚400g,硫代乙酰胺584g加入饱和的HCl/DMF溶液4000ml。于40℃反应48小时,TLC显示反应基本完全,浓缩至干,加入饱和Na2CO3溶液1350ml,搅拌2小时,过滤,烘干得褐色固体(3)465.8g。收率87.6%。In a 5L reaction flask, 400g of p-cyanophenol and 584g of thioacetamide were added to 4000ml of saturated HCl/DMF solution. Reacted at 40°C for 48 hours, TLC showed that the reaction was almost complete, concentrated to dryness, added 1350ml of saturated Na 2 CO 3 solution, stirred for 2 hours, filtered, and dried to obtain 465.8g of brown solid (3). Yield 87.6%.
实施例2:2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(2)的制备Embodiment 2: Preparation of ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (2)
将4-羟基硫代苯甲酰胺(3)465.8g和无水乙醇2.8L加入5L反应瓶中,加热至60℃,滴加2-氯乙酰乙酸乙酯560g,然后回流2小时。然后搅拌下冷却至10℃,过滤,乙醇洗涤,烘干得黄色固体(2)721.1g,收率80.6%。Add 465.8g of 4-hydroxythiobenzamide (3) and 2.8L of absolute ethanol into a 5L reaction flask, heat to 60°C, add 560g of ethyl 2-chloroacetoacetate dropwise, and then reflux for 2 hours. Then it was cooled to 10°C under stirring, filtered, washed with ethanol, and dried to obtain 721.1 g of yellow solid (2), with a yield of 80.6%.
实施例3:2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(1)的制备Example 3: Preparation of ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (1)
将(2)120g、乌洛托品63.8g和三氟乙酸660ml加入3L反应瓶中,加热至100℃反应24小时,然后将反应液浓缩至干,加入水2L搅拌5小时,过滤烘干得126.5g黄色固体(1),收率95.3%。Add 120g of (2), 63.8g of urotropine and 660ml of trifluoroacetic acid into a 3L reaction flask, heat to 100°C for 24 hours, then concentrate the reaction solution to dryness, add 2L of water and stir for 5 hours, filter and dry to obtain 126.5 g of yellow solid (1), yield 95.3%.
实施例4:4-羟基硫代苯甲酰胺(3)的制备Embodiment 4: the preparation of 4-hydroxyl thiobenzamide (3)
在1L反应瓶中,将对氰基苯酚40g,硫代乙酰胺58.4g加入饱和的HCl/甲醇溶液400ml。于20℃反应48小时,TLC显示反应基本完全,浓缩至干,加入饱和Na2CO3溶液至pH为7~8,搅拌2小时,过滤,烘干得褐色固体(3)38g。收率71.5%。In a 1L reaction flask, 40 g of p-cyanophenol and 58.4 g of thioacetamide were added to 400 ml of saturated HCl/methanol solution. Reacted at 20°C for 48 hours, TLC showed that the reaction was almost complete, concentrated to dryness, added saturated Na 2 CO 3 solution until the pH was 7-8, stirred for 2 hours, filtered, and dried to obtain 38 g of brown solid (3). Yield 71.5%.
实施例5:2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(2)的制备Example 5: Preparation of ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (2)
将4-羟基硫代苯甲酰胺(3)38g和无水乙醇200ml加入500ml反应瓶中,加热至80℃,滴加2-氯乙酰乙酸乙酯45.7g,然后回流2小时。然后搅拌下冷却至10℃,过滤,乙醇洗涤,烘干得黄色固体(2)46.7g,收率70.5%。Add 38g of 4-hydroxythiobenzamide (3) and 200ml of absolute ethanol into a 500ml reaction flask, heat to 80°C, add 45.7g of ethyl 2-chloroacetoacetate dropwise, and then reflux for 2 hours. Then it was cooled to 10° C. with stirring, filtered, washed with ethanol, and dried to obtain 46.7 g of yellow solid (2) with a yield of 70.5%.
实施例6:2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(1)的制备Example 6: Preparation of ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (1)
将(2)46.7g、乌洛托品24.8g和三氟乙酸250ml加入500ml反应瓶中,加热至80℃反应24小时,然后将反应液浓缩至干,加入水800ml搅拌5小时,过滤烘干得43.9g橙黄色固体(1),收率85%。Add 46.7g of (2), 24.8g of urotropine and 250ml of trifluoroacetic acid into a 500ml reaction bottle, heat to 80°C and react for 24 hours, then concentrate the reaction solution to dryness, add 800ml of water and stir for 5 hours, filter and dry 43.9 g of orange-yellow solid (1) was obtained, yield 85%.
实施例7:4-羟基硫代苯甲酰胺(3)的制备Embodiment 7: the preparation of 4-hydroxyl thiobenzamide (3)
在1L反应瓶中,将对氰基苯酚40g,硫代乙酰胺58.4g加入饱和的HCl/乙醇溶液400ml。于80℃反应48小时,TLC显示反应基本完全,浓缩至干,加入饱和Na2CO3溶液调节pH至7~8,搅拌2小时,过滤,烘干得褐色固体(3)41g。收率77.1%。In a 1L reaction flask, 40g of p-cyanophenol and 58.4g of thioacetamide were added to 400ml of saturated HCl/ethanol solution. Reacted at 80°C for 48 hours, TLC showed that the reaction was almost complete, concentrated to dryness, added saturated Na 2 CO 3 solution to adjust the pH to 7-8, stirred for 2 hours, filtered, and dried to obtain 41 g of brown solid (3). Yield 77.1%.
实施例8:2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(2)的制备Example 8: Preparation of ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (2)
将4-羟基硫代苯甲酰胺(3)41g和1,4-二氧六环300ml加入500ml反应瓶中,加热至80℃,滴加2-氯乙酰乙酸乙酯49g,然后回流2小时。然后搅拌下冷却至10℃,过滤,乙醇洗涤,烘干得黄色固体(2)49.3g,收率69%。Add 41 g of 4-hydroxythiobenzamide (3) and 300 ml of 1,4-dioxane into a 500 ml reaction flask, heat to 80°C, add 49 g of ethyl 2-chloroacetoacetate dropwise, and then reflux for 2 hours. Then it was cooled to 10° C. with stirring, filtered, washed with ethanol, and dried to obtain 49.3 g of yellow solid (2) with a yield of 69%.
实施例9:2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(1)的制备Example 9: Preparation of ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (1)
将(2)49.3g、乌洛托品26.2g和三氟乙酸270ml加入500ml反应瓶中,加热至120℃反应24小时,然后将反应液浓缩至干,加入水800ml搅拌5小时,过滤烘干得35.8g黄色固体(1),收率65.5%。Add 49.3g of (2), 26.2g of urotropine and 270ml of trifluoroacetic acid into a 500ml reaction bottle, heat to 120°C and react for 24 hours, then concentrate the reaction solution to dryness, add 800ml of water and stir for 5 hours, filter and dry 35.8 g of yellow solid (1) was obtained, yield 65.5%.
实施例10:4-羟基硫代苯甲酰胺(3)的制备Embodiment 10: Preparation of 4-hydroxythiobenzamide (3)
在1L反应瓶中,将对氰基苯酚40g,硫代乙酰胺58.4g加入饱和的HCl/甲醇溶液200ml和饱和的HCl/DMF溶液200ml。于40℃反应48小时,反应液浓缩至干,加入饱和Na2CO3溶液至pH为7~8,搅拌2小时,过滤,烘干得褐色固体(3)36g。收率37.7%。In a 1L reaction flask, 40 g of p-cyanophenol and 58.4 g of thioacetamide were added to 200 ml of saturated HCl/methanol solution and 200 ml of saturated HCl/DMF solution. React at 40°C for 48 hours, concentrate the reaction solution to dryness, add saturated Na 2 CO 3 solution until the pH is 7-8, stir for 2 hours, filter, and dry to obtain 36 g of brown solid (3). Yield 37.7%.
实施例11:2-(4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(2)的制备Example 11: Preparation of ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (2)
将4-羟基硫代苯甲酰胺(3)36g和无水乙醇100ml和1.4-二氧六环100ml加入500ml反应瓶中,加热至80℃,滴加2-氯乙酰乙酸乙酯45.7g,然后回流2小时。然后搅拌下冷却至10℃,过滤,乙醇洗涤,烘干得黄色固体(2)41g,收率65.6%。Add 36g of 4-hydroxythiobenzamide (3), 100ml of absolute ethanol and 100ml of 1.4-dioxane into a 500ml reaction flask, heat to 80°C, add 45.7g of ethyl 2-chloroacetoacetate dropwise, and then Reflux for 2 hours. Then it was cooled to 10° C. with stirring, filtered, washed with ethanol, and dried to obtain 41 g of yellow solid (2) with a yield of 65.6%.
实施例12:2-(3-甲醛基-4-羟基苯基)-4-甲基-5-噻唑甲酸乙酯(1)的制备Example 12: Preparation of ethyl 2-(3-formaldehyde-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate (1)
将(2)41g、乌洛托品21.8g和三氟乙酸20ml和冰醋酸200ml加入500ml反应瓶中,加热至100℃反应24小时,然后将反应液浓缩至干,加入水700ml搅拌5小时,过滤烘干得32g橙黄色固体(1),收率70.6%。Add (2) 41g, 21.8g of urotropine, 20ml of trifluoroacetic acid and 200ml of glacial acetic acid into a 500ml reaction bottle, heat to 100°C for 24 hours, then concentrate the reaction solution to dryness, add 700ml of water and stir for 5 hours, After filtration and drying, 32 g of orange-yellow solid (1) was obtained, with a yield of 70.6%.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710047267 CN101412699A (en) | 2007-10-19 | 2007-10-19 | Preparation of 2-(3-carboxaldehyde-4-hydroxy phenyl)-4-methyl-5-thiazole ethyl formate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710047267 CN101412699A (en) | 2007-10-19 | 2007-10-19 | Preparation of 2-(3-carboxaldehyde-4-hydroxy phenyl)-4-methyl-5-thiazole ethyl formate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101412699A true CN101412699A (en) | 2009-04-22 |
Family
ID=40593466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200710047267 Pending CN101412699A (en) | 2007-10-19 | 2007-10-19 | Preparation of 2-(3-carboxaldehyde-4-hydroxy phenyl)-4-methyl-5-thiazole ethyl formate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101412699A (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101921243A (en) * | 2010-08-14 | 2010-12-22 | 青岛黄海制药有限责任公司 | Method for preparing 2-(3-formacyl-4-isobutoxyphenyl)-4-methyl-1,3 thiazole-5-carboxylic acid ethyl ester |
WO2011031409A1 (en) | 2009-09-10 | 2011-03-17 | Teva Pharmaceutical Industries Ltd. | Processes for preparing febuxostat |
CN102002017A (en) * | 2010-11-02 | 2011-04-06 | 北京赛科药业有限责任公司 | Method for preparing febuxostat intermediate |
WO2011066803A1 (en) * | 2009-12-04 | 2011-06-09 | 重庆医药工业研究院有限责任公司 | Preparation method of intermediate of febuxostat |
CN102702054A (en) * | 2012-06-29 | 2012-10-03 | 晋城海斯制药有限公司 | Preparation method of p-hydroxythiobenzamide |
CN103030605A (en) * | 2012-12-14 | 2013-04-10 | 贵州信邦制药股份有限公司 | Preparation method and detection method of febuxostat raw material |
CN103304512A (en) * | 2013-06-04 | 2013-09-18 | 华南理工大学 | Preparation method for febuxostat |
EP2718272A2 (en) | 2011-06-06 | 2014-04-16 | Hetero Research Foundation | Process for febuxostat |
CN104163782A (en) * | 2013-05-17 | 2014-11-26 | 重庆圣华曦药业股份有限公司 | Preparation method of 3,4-substitituted thiobenzamide and application of 3,4-substitituted thiobenzamide in febuxostat synthesis |
CN104418823A (en) * | 2013-09-02 | 2015-03-18 | 上海龙翔生物医药开发有限公司 | Preparation method of febuxostat intermediate |
CN104529935A (en) * | 2014-12-23 | 2015-04-22 | 浙江华义医药有限公司 | Method for synthesizing high-purity ethyl 2-(3-aldehyde-4-isobutyloxyphenyl)-4-methylthiazole-5-formate |
CN108033929A (en) * | 2017-12-27 | 2018-05-15 | 青岛黄海制药有限责任公司 | A kind of synthetic method of gout suppressant Febustat intermediate impurities and its application for synthesizing impurity |
CN109354584A (en) * | 2018-10-15 | 2019-02-19 | 湖北理工学院 | One-pot synthesis of ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate |
-
2007
- 2007-10-19 CN CN 200710047267 patent/CN101412699A/en active Pending
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011031409A1 (en) | 2009-09-10 | 2011-03-17 | Teva Pharmaceutical Industries Ltd. | Processes for preparing febuxostat |
CN102086169B (en) * | 2009-12-04 | 2014-01-15 | 重庆医药工业研究院有限责任公司 | A kind of preparation method of the intermediate of febuxostat |
WO2011066803A1 (en) * | 2009-12-04 | 2011-06-09 | 重庆医药工业研究院有限责任公司 | Preparation method of intermediate of febuxostat |
CN101921243A (en) * | 2010-08-14 | 2010-12-22 | 青岛黄海制药有限责任公司 | Method for preparing 2-(3-formacyl-4-isobutoxyphenyl)-4-methyl-1,3 thiazole-5-carboxylic acid ethyl ester |
CN102002017B (en) * | 2010-11-02 | 2012-09-26 | 华润赛科药业有限责任公司 | Method for preparing febuxostat intermediate |
CN102002017A (en) * | 2010-11-02 | 2011-04-06 | 北京赛科药业有限责任公司 | Method for preparing febuxostat intermediate |
EP2718272A2 (en) | 2011-06-06 | 2014-04-16 | Hetero Research Foundation | Process for febuxostat |
CN102702054A (en) * | 2012-06-29 | 2012-10-03 | 晋城海斯制药有限公司 | Preparation method of p-hydroxythiobenzamide |
CN103030605A (en) * | 2012-12-14 | 2013-04-10 | 贵州信邦制药股份有限公司 | Preparation method and detection method of febuxostat raw material |
CN104163782A (en) * | 2013-05-17 | 2014-11-26 | 重庆圣华曦药业股份有限公司 | Preparation method of 3,4-substitituted thiobenzamide and application of 3,4-substitituted thiobenzamide in febuxostat synthesis |
CN103304512A (en) * | 2013-06-04 | 2013-09-18 | 华南理工大学 | Preparation method for febuxostat |
CN104418823A (en) * | 2013-09-02 | 2015-03-18 | 上海龙翔生物医药开发有限公司 | Preparation method of febuxostat intermediate |
CN104529935A (en) * | 2014-12-23 | 2015-04-22 | 浙江华义医药有限公司 | Method for synthesizing high-purity ethyl 2-(3-aldehyde-4-isobutyloxyphenyl)-4-methylthiazole-5-formate |
CN104529935B (en) * | 2014-12-23 | 2017-04-12 | 浙江华义医药有限公司 | Method for synthesizing ethyl 2-(3-aldehyde-4-isobutyloxyphenyl)-4-methylthiazole-5-formate |
CN108033929A (en) * | 2017-12-27 | 2018-05-15 | 青岛黄海制药有限责任公司 | A kind of synthetic method of gout suppressant Febustat intermediate impurities and its application for synthesizing impurity |
CN109354584A (en) * | 2018-10-15 | 2019-02-19 | 湖北理工学院 | One-pot synthesis of ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101412699A (en) | Preparation of 2-(3-carboxaldehyde-4-hydroxy phenyl)-4-methyl-5-thiazole ethyl formate | |
TWI358408B (en) | New process for the synthesis of strontium ranelat | |
CN103265420B (en) | A kind of preparation method of aromatic diketone compound | |
CN105175327B (en) | A kind of synthetic method of quinoline | |
CN102086169B (en) | A kind of preparation method of the intermediate of febuxostat | |
CN103396362B (en) | A kind of method preparing dihydroketoacridine acetic acid | |
CN101628909B (en) | Method for synthesizing 1,4-dioxane-2-ketone by ethylene glycol | |
CN105949147A (en) | Green synthesis method of 2-mercaptobenzothiazoles derivatives | |
CN112694453B (en) | Preparation method of N-methylated nitrogen-containing aromatic heterocyclic compound | |
CN101293877A (en) | A kind of method for preparing thiazolidinedione derivatives | |
CN111454230A (en) | Synthesis method of key intermediate Tuv of natural anticancer drug Tubulysins | |
MX2013001768A (en) | Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound. | |
CN106117247B (en) | A kind of preparation method of the cyclohexadione compounds of 2 methyl 1,2,3,9 tetrahydro benzo [b] pyrroles [1,4] thiazine 1,3 | |
CN100503567C (en) | The preparation method of 4-bromo-7-methyl isatin | |
CN110183371B (en) | A kind of preparation technology of zafirlukast intermediate | |
CN102516002B (en) | Preparation technology of optically pure alpha-hydroxy acid and derivatives of the optically pure alpha-hydroxy acid | |
CN100376551C (en) | A kind of synthetic method of semicarbazone | |
CN100360506C (en) | Preparation method of 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one | |
CN115925651B (en) | A kind of photochemical synthesis method of benzoles-2-alkyl alcohols | |
CN105001271B (en) | Neodymium/sodium mixed bimetallic complex and preparation method and application thereof | |
CN110229117A (en) | A kind of novel preparation method of Febustat | |
CN111875557B (en) | Thiazole derivative and synthesis method thereof | |
JP3899626B2 (en) | Preparation of 2-mercaptothiazol | |
CN107056729A (en) | Thiazide derivative and its synthetic method | |
CN108586369B (en) | Preparation method of phenyltriazine compound and preparation method of phenylpyridine compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090422 |